anti-CD19/BCMA U CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-CD19/BCMA U CAR-T cells, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney Disease [EARLY_Phase 1]